Genelabs Technologies, Inc. (GNLB) Reports Results for the Second Quarter and First Six Months of 2008  
8/12/2008 8:58:43 AM

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Genelabs Technologies, Inc. (Nasdaq:GNLB), a biopharmaceutical company focused on the discovery and development of novel compounds for infectious diseases, reported financial results for the second quarter and six months ended June 30, 2008.